Clinical observation and study of anti - aging lyophilized powder granules in human anemia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900028553

Enrollment

Unknown

Registered

2019-12-27

Start date

2020-02-01

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anti-aging

Interventions

Experimental :Anti - aging lyophilized powder particles

Control group:Do not use any anti-aging products

Eligibility

Sex/Gender

All

Age

35 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. aged 35-90 years old; 2. Healthy or sub-healthy people; 3. No infection with HBV/HCV/HIV/TP/EB virus; 4. No history of clinically diagnosed mental illness, no experience of taking or injecting psychotropic drugs; 5. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Exclude patients with clinically diagnosed major diseases; 2. Exclude patients with serious diseases of breast, uterus and ovary; 3. pregnant women.

Design outcomes

Primary

Measure	Time frame
EPO;	—

Contacts

Public ContactChao Xu

Guangzhou reborn health management consultation co., LTD

164972769@qq.com+86 15018720816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026